Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients

Introduction: Diabetes Mellitus (DM) is a metabolic disorder characterised by hyperglycaemia and insufficiency of secretion or action of endogenous insulin. Glycated haemoglobin (HbA1c) is commonly used as reliable index to determine cumulative glycaemic history of preceding 2-3 months. Nitric Oxide...

Full description

Bibliographic Details
Main Authors: Shah Yasir Yousuf, Sudha Ambiger, Dnyanesh Morkar
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2019-09-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/13139/41952_CE[Ra1]_F(KM)_PF1(TR_SHU)_PN(SL).pdf
_version_ 1828467482365526016
author Shah Yasir Yousuf
Sudha Ambiger
Dnyanesh Morkar
author_facet Shah Yasir Yousuf
Sudha Ambiger
Dnyanesh Morkar
author_sort Shah Yasir Yousuf
collection DOAJ
description Introduction: Diabetes Mellitus (DM) is a metabolic disorder characterised by hyperglycaemia and insufficiency of secretion or action of endogenous insulin. Glycated haemoglobin (HbA1c) is commonly used as reliable index to determine cumulative glycaemic history of preceding 2-3 months. Nitric Oxide (NO) is a potent vasodilator and an endothelium-relaxing factor. Low serum Nitric Oxide (NO) levels are known to be associated with endothelial dysfunction in Type 2 Diabetes Mellitus (T2DM). Aim: To estimate the serum nitric oxide levels in type 2 diabetic patients and correlate it with serum HbA1c levels. Materials and Methods: The cross-sectional study comprised of 100 (50 male and 50 female) T2DM patients who attended KLE’S Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi, Karnataka, India. Fasting Plasma Glucose (FPG) was measured by Hexokinase method using Roche/Hitachi COBAS 6000 Fully Automated Analyser. HbA1c was estimated using a Bio-Rad D-10 HbA1c program and serum NO was estimated by Classical Griess Reaction. Data was analysed using independent t-test within the groups and Karl Pearson Correlation Coefficient in between the groups. The p<0.05 was considered as statistically significant. Results: Statistically significant positive correlation was observed between NO and with HbA1c (r=0.7674) and NO with FBS (r=0.5688). Conclusion: Hyperglycaemia increases NO levels in T2DM patients. Measurement of nitric oxide in early course of diabetes may help in preventing the progression and development of complications like endothelial dysfunction.
first_indexed 2024-12-11T04:07:50Z
format Article
id doaj.art-bc8e17915fd745c4a5fa914bde29d570
institution Directory Open Access Journal
issn 2249-782X
0973-709X
language English
last_indexed 2024-12-11T04:07:50Z
publishDate 2019-09-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj.art-bc8e17915fd745c4a5fa914bde29d5702022-12-22T01:21:29ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2019-09-01139BC04BC0610.7860/JCDR/2019/41952.13139Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus PatientsShah Yasir Yousuf0Sudha Ambiger1Dnyanesh Morkar2Student, Department of Biochemistry, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.Assistant Professor, Department of Biochemistry, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.Associate Professor, Department of General Medicine, Jawaharlal Nehru Medical College, Belagavi, Karnataka, India.Introduction: Diabetes Mellitus (DM) is a metabolic disorder characterised by hyperglycaemia and insufficiency of secretion or action of endogenous insulin. Glycated haemoglobin (HbA1c) is commonly used as reliable index to determine cumulative glycaemic history of preceding 2-3 months. Nitric Oxide (NO) is a potent vasodilator and an endothelium-relaxing factor. Low serum Nitric Oxide (NO) levels are known to be associated with endothelial dysfunction in Type 2 Diabetes Mellitus (T2DM). Aim: To estimate the serum nitric oxide levels in type 2 diabetic patients and correlate it with serum HbA1c levels. Materials and Methods: The cross-sectional study comprised of 100 (50 male and 50 female) T2DM patients who attended KLE’S Dr. Prabhakar Kore Hospital and Medical Research Centre, Belagavi, Karnataka, India. Fasting Plasma Glucose (FPG) was measured by Hexokinase method using Roche/Hitachi COBAS 6000 Fully Automated Analyser. HbA1c was estimated using a Bio-Rad D-10 HbA1c program and serum NO was estimated by Classical Griess Reaction. Data was analysed using independent t-test within the groups and Karl Pearson Correlation Coefficient in between the groups. The p<0.05 was considered as statistically significant. Results: Statistically significant positive correlation was observed between NO and with HbA1c (r=0.7674) and NO with FBS (r=0.5688). Conclusion: Hyperglycaemia increases NO levels in T2DM patients. Measurement of nitric oxide in early course of diabetes may help in preventing the progression and development of complications like endothelial dysfunction.https://jcdr.net/articles/PDF/13139/41952_CE[Ra1]_F(KM)_PF1(TR_SHU)_PN(SL).pdfdiabetic complicationsendothelial dysfunctionglycated haemoglobingriess reaction
spellingShingle Shah Yasir Yousuf
Sudha Ambiger
Dnyanesh Morkar
Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
Journal of Clinical and Diagnostic Research
diabetic complications
endothelial dysfunction
glycated haemoglobin
griess reaction
title Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
title_full Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
title_fullStr Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
title_full_unstemmed Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
title_short Serum Nitric Oxide and Plasma HbA1c Levels in Type 2 Diabetes Mellitus Patients
title_sort serum nitric oxide and plasma hba1c levels in type 2 diabetes mellitus patients
topic diabetic complications
endothelial dysfunction
glycated haemoglobin
griess reaction
url https://jcdr.net/articles/PDF/13139/41952_CE[Ra1]_F(KM)_PF1(TR_SHU)_PN(SL).pdf
work_keys_str_mv AT shahyasiryousuf serumnitricoxideandplasmahba1clevelsintype2diabetesmellituspatients
AT sudhaambiger serumnitricoxideandplasmahba1clevelsintype2diabetesmellituspatients
AT dnyaneshmorkar serumnitricoxideandplasmahba1clevelsintype2diabetesmellituspatients